PDF | ADAM8 is expressed widely in breast cancer and predicts poor outcome in hormone receptor positive, HER-2 negative patients. | ID: tm70n9369

ADAM8 is expressed widely in breast cancer and predicts poor outcome in hormone receptor positive, HER-2 negative patients.

Pianetti, Stefania.

Miller, Kathy D

Chen, Hannah H

Althouse, Sandra.

Cao, Sha.

Michael, Steven J

Sonenshein, Gail E

Mineva, Nora D

2023

Description

Keywords: ADAM8, Breast cancer, Biomarker, Immunohistochemistry, Diagnosis, Prognosis.

Springer Open.

This object is in collection

Permanent URL

Citation

Stefania Pianetti, et. al. "ADAM8 is expressed widely in breast cancer and predicts poor outcome in hormone receptor positive, HER-2 negative patients." Cancer Cell International, BioMed Central, London, v.23, no.1, 2023